Completed
Asymptomatic Carotid Artery Plaque Study (ACAPS)
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-05-13
N/A
Participants Needed
N/A
Research Sites
534 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine whether warfarin or lovastatin alone or in combination retarded the progression of atherosclerotic plaques in the carotid arteries of high risk individuals with asymptomatic carotid stenosis. Also, to determine if a full scale trial was feasible.
CONDITIONS
Official Title
Asymptomatic Carotid Artery Plaque Study (ACAPS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
Men and women with early carotid atherosclerosis and moderately elevated LDL cholesterol between the 60th and 90th percentiles.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
PREVENTION
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here